{'fraction_non_alphanumeric': 0.04119850187265917, 'fraction_numerical': 0.009363295880149813, 'mean_word_length': 4.893382352941177, 'pattern_counts': {'":': 0, '<': 1, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Effect of Surfactin Administration on Glucose and Lipid Metabolism in Mice Fed a High Fat Diet

The high intake of high fat diet has been related with several changes on glucose and lipid metabolism and also on gut microbiota composition. Surfactin is an active compound produced by a wide variety of bacteria, fungi, and yeast that have important biological activities as anti‐tumour, anti‐microbial and anti‐inflammatory. Oral probiotics or their secreted factors are becoming the novel strategy for treatment of metabolism alterations. The aim of this study was to determine the influence of surfactin produced by Bacillus subtilis (ATCC 19659) on glucose and lipid metabolism in mice fed a high fat diet. Male mice (n=6/group) were fed with a control (C) or high fat (HF) diets and water ad libitum for 10 weeks. One group (HFS) was orally administrated with 5 mg/kg body weight of Surfactin once a week for 4 doses. Surfactin was isolated and purified from Bacillus subtilis culture. It was lyophilized and later dissolved in phosphate buffered saline (PBS) before the administration. Food (g) and water intake (ml) were measured daily. Body weight (g) was evaluated weekly. After 10 weeks, mice were euthanized and blood was collected. Using commercial kits the levels (mg/dl) of glucose (GLU), triglycerides (TG), total cholesterol (CHO), HDL and VLDL cholesterol were measured. Epididymal (EAT) and retroperitoneal (RAT) adipose tissue depots were collected and weighted (g). Results were expressed as mean ± SEM. Data were analyzed using T‐test. P<0.05 was considered significant for all data.